keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Endotoxin Inhibitor TFA is a synthetic peptide that exhibits high-affinity binding to lipid A, effectively detoxifying LPS and impeding LPS-induced cytokine release in vivo. It also suppresses the febrile response to LPS while demonstrating minimal toxicity and lethality [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Endotoxin Inhibitor TFA is a synthetic peptide that exhibits high-affinity binding to lipid A, effectively detoxifying LPS and impeding LPS-induced cytokine release in vivo. It also suppresses the febrile response to LPS while demonstrating minimal toxicity and lethality [1]. |
In vivo | The endotoxin inhibitor TFA, when administered intraperitoneally (i.p.) at a dose of 0.5 mg/kg, significantly reduces the heat exposure-induced increase in the mRNA levels of IL-1β, COX-2, IκB-β, and LPS activity. Additionally, it mitigates the hypothermia and plasma ACTH and catecholamine responses elicited by heat exposure in aged rats [1]. |
Molecular Weight | 1908.72 |
Formula | C67H103F18N15O24S2 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Endotoxin inhibitor TFA inhibitor inhibit